73 related articles for article (PubMed ID: 410583)
1. [Dynamic evaluation of GH secretion in acromegaly as a criterion for the choice of treatment].
Jannì A; Carmina E; Lanzara P; Lo Coco R; Longo RA
Clin Ter; 1977 Aug; 82(3):203-12. PubMed ID: 410583
[No Abstract] [Full Text] [Related]
2. Effects of pirenzepine, bromocriptine and their association on basal and GHRH- and TRH-induced GH secretion in acromegaly.
Fiszlejder L; Penacini O; Ratz S; Storani M; Oneto A; Guitelman A
Horm Res; 1991; 36(1-2):47-51. PubMed ID: 1814801
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic control of growth hormone secretion in normal and acromegalic subjects.
Molinatti GM; Camanni F; Massara F; Isaia GC
Panminerva Med; 1975 Apr; 17(4):101-6. PubMed ID: 1153217
[No Abstract] [Full Text] [Related]
4. Bromoergocriptine and growth hormone (GH) dynamics in health and hypersomatotropism.
Sachdev Y
J Assoc Physicians India; 1983 Apr; 31(4):195-9. PubMed ID: 6417104
[No Abstract] [Full Text] [Related]
5. Effect of the acute administration of haloperidol and pimozide on plasma GH levels in acromegaly.
Carmina E; Lo Coco R; Lanzara P; Jannì A
Acta Endocrinol (Copenh); 1979 Aug; 91(4):609-15. PubMed ID: 115193
[TBL] [Abstract][Full Text] [Related]
6. Plasma growth hormone and prolactin responses to TRH and arginine given before and during bromocriptine therapy to patients with acromegaly.
Hanew K; Sasaki A; Mouri T; Yoshinaga K
Acta Endocrinol (Copenh); 1980 Nov; 95(3):298-307. PubMed ID: 6776756
[No Abstract] [Full Text] [Related]
7. [TRH-stimulated growth hormone secretion in acromegaly. Therapeutic results with 188 patients].
Eversmann T; Lüdeke U; Fahlbusch R; von Werder K
Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1091-6. PubMed ID: 3089753
[TBL] [Abstract][Full Text] [Related]
8. [Acromegaly. Recent physiopathological and therapeutic acquisitions].
Silvestrini F
Minerva Med; 1979 Mar; 70(15):1065-8. PubMed ID: 108635
[No Abstract] [Full Text] [Related]
9. [Response of growth hormone to sandostatin and bromocriptine and prognostic value of prolactin levels in serum and thyroliberin test in patients with active acromegaly].
Gasińska T; Nowak S
Endokrynol Pol; 1993; 44(4):455-65. PubMed ID: 8055814
[TBL] [Abstract][Full Text] [Related]
10. [Bromocryptin effect on growth hormone and prolactin secretion after administration of thyrotropin-releasing hormone in patients with primary hypothyroidism and acromegaly (author's transl)].
Felt V; Nedvídková J; Krejcík L; Hainer V
Cas Lek Cesk; 1977 May; 116(19):591-4. PubMed ID: 406999
[No Abstract] [Full Text] [Related]
11. [Endocrinological aspects of the dopaminergic control of somatotropin in patients with acromegaly].
Gragnoli G; Martinelli G; Tanganelli I; Signorini AM; Pallassini A
Boll Soc Ital Biol Sper; 1977 Oct; 53(19):1620-6. PubMed ID: 607965
[No Abstract] [Full Text] [Related]
12. Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995.
Barkan AL; Kelch RP; Hopwood NJ; Beitins IZ
J Clin Endocrinol Metab; 1988 Jan; 66(1):16-23. PubMed ID: 2891720
[TBL] [Abstract][Full Text] [Related]
13. Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effect on serum levels of somatomedin C.
Moses AC; Molitch ME; Sawin CT; Jackson IM; Biller BJ; Furlanetto R; Reichlin S
J Clin Endocrinol Metab; 1981 Oct; 53(4):752-8. PubMed ID: 6793607
[TBL] [Abstract][Full Text] [Related]
14. Effect of bromocriptine on serum hormones in acromegaly.
Carlson HE; Levin SR; Braunstein GD; Spencer EM; Wilson SE; Hershman JM
Horm Res; 1984; 19(3):142-52. PubMed ID: 6425186
[TBL] [Abstract][Full Text] [Related]
15. Effect of ergot alkaloids on growth hormone and prolactin secretion in humans.
Silvestrini F; Liuzzi A; Chiodini PG
Pharmacology; 1978; 16 Suppl 1():78-87. PubMed ID: 643905
[TBL] [Abstract][Full Text] [Related]
16. [Effects on growth hormone secretion of a new somatostatin analogue (SMS 201-995) and nonspecific releasing hormones in patients with acromegaly].
Candrina R
Medicina (Firenze); 1988; 8(2):180-1. PubMed ID: 3147351
[No Abstract] [Full Text] [Related]
17. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
Felt V; Nedvídková J
Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
[No Abstract] [Full Text] [Related]
18. [Use of thyroliberin and parlodel in acromegaly].
Pronin VS
Vestn Akad Med Nauk SSSR; 1981; (6):71-4. PubMed ID: 6794239
[No Abstract] [Full Text] [Related]
19. [Acromegaly. Physiopathological aspects and description of a clinical case].
Coppola A; Spera C; Buono V; Esposito C; Nasti A
Minerva Med; 1986 Mar; 77(11):395-401. PubMed ID: 3085021
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of growth hormone secretion in untreated acromegaly.
Dash RJ; Rao NS; Sriprakash ML; Sialy R
J Assoc Physicians India; 1987 May; 35(5):341-3. PubMed ID: 3121582
[No Abstract] [Full Text] [Related]
[Next] [New Search]
